Compared to EGFL6 levels in tumors, it was found EGFL6 was overexpressed in lung cancer, colorectal cancer, breast cancer, nasopharyngeal cancer, ovarian cancer, and hepatocellular carcinoma [10, 11, 21–23]. This evidence concerns the gene EGFL6 and lung carcinoma.